Clinical Potential of Tissue Tumor Mutational Burden (tTMB) and Blood TMB (bTMB) as a Biomarker in Non-Small Cell Lung Cancer

被引：0
|
作者：
Zhou, J. [1 ]
Zhou, J. [1 ]
Chen, X. [1 ]
Zhu, Y. [1 ]
Fang, L. [1 ]
Bao, Z. [1 ]
Liu, R. [1 ]
Cao, H. [1 ]
Sun, W. [1 ]
Zhang, T. [2 ]
Lin, J. [2 ]
Yu, B. [2 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Resp Dis, Thorac Dis Ctr,Coll Med, Hangzhou, Zhejiang, Peoples R China
[2] Burning Rock Biotech, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
tTMB; bTMB; NSCLC;
D O I：
10.1016/j.jtho.2019.08.751
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-36
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [1] Non-small cell lung cancer (NSCLC) with higher blood tumor mutational burden (bTMB)/tissueTMB (tTMB) ratio is associated with inferior survival outcome
    Kim, Leeseul
    Park, Jewel
    Oh, Youjin
    Chae, Young Kwang
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Blood tumor mutational burden (bTMB) from circulating tumor DNA (ctDNA) as a biomarker for both mutational status and tumor burden in non-small cell lung cancer (NSCLC)
    Davis, Andrew A.
    Galvez, Carlos
    Pan, Alan
    Mohindra, Nisha
    Villaflor, Victoria
    Chae, Young Kwang
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer
    Chae, Young Kwang
    Davis, Andrew A.
    Agte, Sarita
    Pan, Alan
    Simon, Nicholas I.
    Iams, Wade T.
    Cruz, Marcelo R.
    Tamragouri, Keerthi
    Rhee, Kyunghoon
    Mohindra, Nisha
    Villaflor, Victoria
    Park, Wungki
    Lopes, Gilberto
    Giles, Francis J.
    ONCOLOGIST, 2019, 24 (06): : 820 - 828
  • [4] Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer
    Boumber, Yanis
    JOURNAL OF THORACIC DISEASE, 2018, 10 (08) : 4689 - 4693
  • [5] The clinical utility of tumor mutational burden in non-small cell lung cancer
    Greillier, Laurent
    Tomasini, Pascale
    Barlesi, Fabrice
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 639 - 646
  • [6] Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Ma, Yuhui
    Li, Quan
    Du, Yaxi
    Cai, Jingjing
    Chen, Wanlin
    Zhao, Guangqiang
    Liu, Xing
    Li, Hongsheng
    Ma, Luyao
    Huang, Yunchao
    Zhou, Yongchun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Non-Small Cell Lung Cancer as a Precision Oncology Paradigm: Emerging Targets and Tumor Mutational Burden (TMB)
    Tafe, Laura J.
    ADVANCES IN ANATOMIC PATHOLOGY, 2020, 27 (01) : 3 - 10
  • [8] Comparison of platforms for determining tumor mutational burden (TMB) from blood samples in patients with non-small cell lung cancer (NSCLC)
    Baden, J.
    Chang, H.
    Greenawalt, D. M.
    Kirov, S.
    Pant, S.
    Seminara, A.
    Srinivasan, S.
    Green, G.
    ANNALS OF ONCOLOGY, 2019, 30 : 28 - 28
  • [9] Tumor mutational burden profile (TMB) of oncogenic driver mutations in non small cell lung cancer
    Walker, Paul
    Sharma, Nitika
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [10] Variant Detection and Tumor Mutational Burden (TMB) Concordance in Blood and Tumor Tissue Using Next-Generation Sequencing (NGS) in Patients with Non-small Cell Lung Cancer (NSCLC)
    Baden, J.
    Chang, H.
    Greenawalt, D. M.
    Kirov, S.
    Pant, S.
    Seminara, A.
    Srinivasan, S.
    Green, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1170 - 1170
12345